FGFR2 and intrahepatic cholangiocarcinoma: A clinical response was noted for a patient with intrahepatic cholangiocarcinoma with a known FGFR2 fusion, additionally prolonged stable disease was observed in 10 of 61 patients, including a cholangiocarcinoma, which also had an FGFR2 fusion [57].